Leonard B. Saltz, MD [clinicaltrials_resource:61310b50604d5d92b9928412f8fd7da8]
Irinotecan in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00003544]Combination Chemotherapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003956]Irinotecan in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00004051]Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum [clinicaltrials:NCT00005860]Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer [clinicaltrials:NCT00020917]Cetuximab in Treating Patients With Stage IV Colorectal Cancer [clinicaltrials:NCT00020930]Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors [clinicaltrials:NCT00027638]Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00027729]Pyroxamide in Treating Patients With Advanced Cancer [clinicaltrials:NCT00042900]Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00049101]Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer [clinicaltrials:NCT00077259]
overall official [clinicaltrials_vocabulary:overall-official]
Leonard B. Saltz, MD [clinicaltrials_resource:61310b50604d5d92b9928412f8fd7da8]
Bio2RDF identifier
61310b50604d5d92b9928412f8fd7da8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:61310b50604d5d92b9928412f8fd7da8
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Leonard B. Saltz, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:61310b50604d5d92b9928412f8fd7da8
title
Leonard B. Saltz, MD
@en
type
label
Leonard B. Saltz, MD [clinicaltrials_resource:61310b50604d5d92b9928412f8fd7da8]
@en